Immunohistochemical analysis from the ccRCC validation cohort revealed that EFTUD2 expression is predominantly within the nuclei of tumor cells, while PROM1 is located in the cytoplasm (Figure 2). Here, PROM1 is linked to nonpapillary renal cell carcinoma.